Publication | Closed Access

Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment

Cell-based Drug DeliveryNanomedicineProgrammable DeliveryDrug TargetingPolymer-drug ConjugateMedicineNano-drug DeliveryTumor TargetingCancer TreatmentPharmacologyRadiation OncologyTumor-targeting Peptide-drug ConjugateTumor BiologyDrug Discovery